Since its inception in 2020, Impilo has rapidly positioned itself at the forefront of healthcare innovation, using cutting-edge technology to eliminate the barriers to receiving care at home. In a ...
PHILADELPHIA, Jan. 12, 2026 /PRNewswire/ -- Today, Impilo announced the launch of a new AI-powered support experience for its e-commerce store, The Digital Health Store, bringing intelligent, ...
NEW YORK, June 16, 2025--(BUSINESS WIRE)--Ash, a leading at-home health testing platform, and Impilo, a leader in enabling at-home healthcare through its tech-enabled healthcare logistics and ...
PHILADELPHIA, Jan. 7, 2026 /PRNewswire/ -- Impilo, a leader in next-generation connected care solutions, today announced its strategic expansion of physical operations with new warehouse facilities in ...
PHILADELPHIA, April 17, 2025 /PRNewswire/ -- Impilo, a leader in enabling at-home healthcare through connected device and diagnostics operations, is excited to announce it has joined the Elation ...
– Impilo, a digital health platform revolutionizing healthcare access raises $11.5M in a Series A funding round led by Construct Capital, with participation from GC 1 Capital, One Way Ventures, 2048 ...
KKR has agreed to buy into Immedica Pharma, a pharmaceutical company focused on the commercialization of medicines for rare diseases and speciality care products. Immedica’s existing owner Impilo will ...
STOCKHOLM & LONDON--(BUSINESS WIRE)-- Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, ...
Impilo and SHS have acquired Lowenco, a maker of ultra-low temperature storage solutions for the pharmaceutical industry. No financial terms were disclosed. Brown Gibbons Lang & Company was financial ...
Impilo has invested in a 29% stake in Cavidi AB, an Uppsala-based diagnostics company focused on HIV Viral Load monitoring. Cavidi has developed a new fully automated viral load diagnostic platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results